Arnon P. Kater, Yanwen Jiang, Brenda Chyla, John F. Seymour. Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab. Haematologica 2020;105(7):e382-e383; https://doi.org/10.3324/haematol.2020.253849.